Post-marketing safety surveillance of Infanrix hexa and DTPa-IPV/Hib booster schedule in healthy infants

Phase 3, open-label, single-arm trial of pertussis filamentous haemagglutinin, acthib + dpt-ipv and Hepatitis B vaccine in diphtheria, Tetanus, pertussis and 3 more, sponsored by GSK. Primary endpoints: Occurrence of solicited local adverse events and Occurrence of solicited general adverse events.